Dr Jaroslav Boublik initially trained as an endocrine receptor biologist and peptide chemist. In the early 1990s, Dr Boublik made a shift into nutritional medicine, initially with a focus on human hydration research, and later more broadly in nutritional supplement research and development. Most recently he has shifted focus again to two areas of therapeutics set to disrupt current medical practice – cannabinoids and probiotics. Dr Boublik sits on the board of several leading companies in the nutritional and complementary medicine industry.

Director & Chief Science Officer/Biome Australia Ltd

JAROSLAV BOUBLIK

Session:

CLINICAL PHARMACY UPDATE: The potential of probiotics for the management of paediatric asthma

When:

Proudly sponsored by:

© 2022 APP Conference. All Rights Reserved.

The 2022 Australian Pharmacy Professional Conference is proudly sponsored by: